{"id":"W2915431268","doi":"10.1007/s00432-019-02862-x","title":"First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression","year":2019,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; McGill University Health Centre","funders":"Boehringer Ingelheim","keywords":"Afatinib; Gefitinib; Medicine; Internal medicine; Lung cancer; Hazard ratio; Tolerability; Oncology; Adverse effect; Gastroenterology; Epidermal growth factor receptor; Surgery; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002526147,0.0005273731,0.001432296,0.0002501825,0.0001709813,0.0005692401,0.0005196609,0.0005906384,0.001970971],"category_scores_gemma":[0.002199997,0.0002131118,0.002487076,0.0001922779,0.0004376015,0.0005067417,0.0002910904,0.0009565285,0.0002098211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007494714,"about_ca_system_score_gemma":0.000943786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004340213,"about_ca_topic_score_gemma":0.001653525,"domain_scores_codex":[0.9987184,0.0008520274,0.00007033685,0.0001677804,0.00009754043,0.00009398638],"domain_scores_gemma":[0.9985274,0.0006127516,0.0004270167,0.0001045148,0.0000668387,0.0002614174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9071733,0.00284202,0.02837512,0.0004253883,0.003183739,0.0000596489,0.00007246644,0.001610902,0.007357465,0.00008988062,0.0005037739,0.04830637],"study_design_scores_gemma":[0.401577,0.4598267,0.1181661,0.00006906008,0.005371505,0.0005053833,0.00007209514,0.006300189,0.005864665,0.0004419168,0.001742149,0.00006327871],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981462,0.0009259557,0.0001788594,0.00009102882,0.00002300757,0.0001558509,0.0001396864,0.00001703519,0.0003224397],"genre_scores_gemma":[0.9983865,0.0001976795,0.0004098817,0.0001173919,0.0000405673,0.0001479463,0.0004227,0.000005149326,0.000272205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002526147,"threshold_uncertainty_score":0.01335973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04627148785334907,"score_gpt":0.5548936099905363,"score_spread":0.5086221221371872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}